The John S. Dunn, GCC for Chemical Genomics (GCC CG) was organized in 2003 to address the growing need among Gulf Coast investigators for a centralized capability to support high throughput screening technologies. Many Gulf Coast institution research laboratories were engaged in screening projects but they were generally too small to be effective. To reduce the duplication of effort and to expand the screening capabilities, the GCC CG was organized as a research consortium to bring together scientists interested in this area of research with the aim of developing an inter-institutional academic drug discovery program.
GCC CG Screening Lab and Satellite Facilities: Automation equipment for assay development and central screening laboratories
GCC CG member institutions also include:
Texas A&M Institute of Biosciences and Technology
Combinatorial Drug Facility (Texas Screening Alliance for Cancer Therapeutics)
The University of Texas at Austin
Small Molecule Facility (Texas Screening Alliance for Cancer Therapeutics)
Houston Methodist Research Institute
Zebrafish Core Facilities
Advanced Cellular & Tissue Microscopy (ACTM) Core
Please use this link for
The above cores are open to GCC and Texas Medical Center researchers.
12/02/2016Keck Seminar, Patrick Barth, Assistant Professor, Department of Pharmacology, Baylor College of MedicineBioScience Research Collaborative